Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 13, 2017

View Archived Issues

AmorChem Holdings spins out two new companies

Silence Therapeutics acquires equity stake in Arrowhead Pharmaceuticals

Allergan licenses rights to Assembly Biosciences' microbiome programs

FDA accepts Adaptimmune's IND for T-cell therapy targeting MAGE-A4

Vescor formed to develop autophagy therapeutics

FASN inhibitors reported in Teva patent

Chongqing University reports PDE5A inhibitors

NeuroVive, Karolinska Institutet enter collaboration for cyclophilin inhibitor

Moderna Therapeutics: developing mRNA therapeutics

Lumason obtains FDA approval for the use in ultrasonography

Servier and Vernalis jointly patent Mcl-1 inhibitors

Shionogi's cefiderocol shows positive results in cUTI study

Novartis to conduct phase II study of bimagrumab

EC approves Novo Nordisk's Fiasp for diabetes

Amgen and Immatics Biotechnologies collaborate on novel bispecific cancer immunotherapies

Bayer describes BUB1 inhibitors for cancer

Wockhardt reports antibacterial activity enhancers

Tasly Pharmaceutical describes platelet aggregation inhibitors

Crinetics Pharmaceuticals presents somatostatin receptor agonists

Update on clinical trials of dendritic cell vaccine TLP0-001

Takara Bio applies to conduct Japanese phase I/II study of CAR therapy

Protein Sciences Zika vaccine shows good safety results in preclinical studies

Phase I results from ZUMA-1 trial of KTE-C19 in patients with refractory DLBCL

MedImmune initiates phase I/Ib study of MEDI-3726 in metastatic castration-resistant prostate cancer

CRISPR Cas9 gene repair strategy shows promise for treatment of X-CGD

ViraCyte's T-cell immunotherapy wins FDA fast track, orphan designations

Heron Therapeutics submits NDA for Cinvanti in U.S.

Phase I trial explores MK-7684 alone and in combination with pembolizumab in advanced solid tumors

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...